NASDAQ:NVOS - Nasdaq - US67011T3005 - Common Stock - Currency: USD
0.15
-0.02 (-13.29%)
The current stock price of NVOS is 0.15 USD. In the past month the price decreased by -39.27%. In the past year, price decreased by -90.74%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.74 | 87.89B | ||
CVS | CVS HEALTH CORP | 12.24 | 83.63B | ||
LH | LABCORP HOLDINGS INC | 17.37 | 21.10B | ||
DGX | QUEST DIAGNOSTICS INC | 19.46 | 19.48B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 15.88 | 14.07B | ||
DVA | DAVITA INC | 15.48 | 11.76B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 115.35 | 11.05B | ||
CHE | CHEMED CORP | 25.75 | 8.72B | ||
HIMS | HIMS & HERS HEALTH INC | 66.57 | 7.99B | ||
OPCH | OPTION CARE HEALTH INC | 27.88 | 5.62B | ||
CRVL | CORVEL CORP | 26.02 | 5.59B | ||
GH | GUARDANT HEALTH INC | N/A | 4.86B |
Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 127 full-time employees. The company went IPO on 2005-07-12. The firm owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The firm operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.
NOVO INTEGRATED SCIENCES INC
11120 Ne 2Nd Street, Suite 100
Bellevue WASHINGTON 98004 US
CEO: Robert Mattacchione
Employees: 179
Company Website: https://www.novointegrated.com/
Phone: 12066179797
The current stock price of NVOS is 0.15 USD. The price decreased by -13.29% in the last trading session.
The exchange symbol of NOVO INTEGRATED SCIENCES INC is NVOS and it is listed on the Nasdaq exchange.
NVOS stock is listed on the Nasdaq exchange.
NOVO INTEGRATED SCIENCES INC (NVOS) has a market capitalization of 2.86M USD. This makes NVOS a Nano Cap stock.
NOVO INTEGRATED SCIENCES INC (NVOS) currently has 179 employees.
NOVO INTEGRATED SCIENCES INC (NVOS) has a resistance level at 0.18. Check the full technical report for a detailed analysis of NVOS support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NVOS does not pay a dividend.
NOVO INTEGRATED SCIENCES INC (NVOS) will report earnings on 2024-12-11, after the market close.
NOVO INTEGRATED SCIENCES INC (NVOS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.38).
The outstanding short interest for NOVO INTEGRATED SCIENCES INC (NVOS) is 0.01% of its float. Check the ownership tab for more information on the NVOS short interest.
ChartMill assigns a fundamental rating of 1 / 10 to NVOS. Both the profitability and financial health of NVOS have multiple concerns.
Over the last trailing twelve months NVOS reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS increased by 84.52% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -68.87% | ||
ROE | -244.36% | ||
Debt/Equity | 0.16 |